A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer
- PMID: 25515196
- DOI: 10.1245/s10434-014-4276-3
A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer
Abstract
Background: Microsurgical techniques for the treatment of lymphedema rapidly increased in popularity. Although surgical success with vascularized lymph node (VLN) transfer has been demonstrated, limited studies have investigated the influence of microsurgical treatments on health-related quality-of-life (HRQoL) parameters. The aim of this study was to prospectively evaluate changes in HRQoL following VLN transfer for upper- and lower-extremity lymphedema using a validated instrument.
Methods: An Institutional Review Board-approved prospective study was performed of patients who underwent VLN transfer for symptomatic upper- or lower-limb lymphedema. A validated lymphedema-specific questionnaire-lymphoedema quality-of-life study-was utilized to assess specific quality-of-life parameters at multiple time points during the 12-month perioperative period. For a comparison with HRQoL metrics, limb circumference measurements were obtained to assess circumference differentiation.
Results: Twenty-five patients met the study criteria. Limb circumference analysis revealed significant early improvements following VLN transfer, with continued improvement during the study period (upper-limb lymphedema: 24.4 %; lower-limb lymphedema: 35.2 %). These improvements were mirrored by improvements in all HRQoL domains and overall quality of life (p < 0.01). The function, body appearance, symptom, and mood domains were all found to be significantly improved during the postoperative evaluation, with continued improvement being reported throughout the study period (p < 0.01 within each domain).
Conclusions: Microsurgical treatment of lymphedema with VLN transfer procedures effectively decrease limb circumference. This improvement is mirrored by improvements in patient-reported outcomes and quality of life. These changes can be observed as soon as 1 month postoperatively, and continued steady improvement can be expected.
Similar articles
-
From theory to evidence: long-term evaluation of the mechanism of action and flap integration of distal vascularized lymph node transfers.J Reconstr Microsurg. 2015 Jan;31(1):26-30. doi: 10.1055/s-0034-1381957. Epub 2014 Aug 19. J Reconstr Microsurg. 2015. PMID: 25137504
-
Double gastroepiploic vascularized lymph node tranfers to middle and distal limb for the treatment of lymphedema.Microsurgery. 2017 Oct;37(7):771-779. doi: 10.1002/micr.30168. Epub 2017 Mar 23. Microsurgery. 2017. PMID: 28334445
-
The laparoscopic right gastroepiploic lymph node flap transfer for upper and lower limb lymphedema: Technique and outcomes.Microsurgery. 2017 Mar;37(3):197-205. doi: 10.1002/micr.22450. Epub 2015 Jul 15. Microsurgery. 2017. PMID: 26175309
-
Latissimus dorsi flap with vascularized lymph node transfer for lymphedema treatment: Technique, outcomes, indications and review of literature.J Surg Oncol. 2017 Jan;115(1):72-77. doi: 10.1002/jso.24347. Epub 2016 Dec 12. J Surg Oncol. 2017. PMID: 27943281 Review.
-
Free vascularized lymph node transfer for treatment of lymphedema: A systematic evidence based review.J Plast Reconstr Aesthet Surg. 2016 Sep;69(9):1234-47. doi: 10.1016/j.bjps.2016.06.022. Epub 2016 Jul 1. J Plast Reconstr Aesthet Surg. 2016. PMID: 27425000 Review.
Cited by
-
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND).Front Pharmacol. 2024 Sep 4;15:1457363. doi: 10.3389/fphar.2024.1457363. eCollection 2024. Front Pharmacol. 2024. PMID: 39318780 Free PMC article.
-
Surgical treatment algorithm for breast cancer lymphedema-a systematic review.Gland Surg. 2024 May 30;13(5):722-748. doi: 10.21037/gs-23-503. Epub 2024 May 27. Gland Surg. 2024. PMID: 38845835 Free PMC article. Review.
-
Lymphoedema surgery in Australia: a narrative review.Gland Surg. 2023 Dec 26;12(12):1823-1834. doi: 10.21037/gs-23-181. Epub 2023 Dec 12. Gland Surg. 2023. PMID: 38229851 Free PMC article. Review.
-
A new lymphedema treatment using pyro-drive jet injection.Hum Cell. 2024 Mar;37(2):465-477. doi: 10.1007/s13577-023-01021-2. Epub 2024 Jan 14. Hum Cell. 2024. PMID: 38218753
-
Surgical management of breast cancer-related lymphedema: a narrative review of contemporary practices.Ann Transl Med. 2023 Dec 20;11(12):418. doi: 10.21037/atm-23-292. Epub 2023 Oct 16. Ann Transl Med. 2023. PMID: 38213809 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
